Association between race and follow‐up diagnostic care after a positive prostate cancer screening test in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial
Daniel A. Barocas(Vanderbilt University Medical Center), E. David Crawford(University of California San Diego), David F. Penson(Geriatric Research Education and Clinical Center), Amanda Black(St. Elizabeth's Hospital), Jay H. Fowke(Vanderbilt University Medical Center), Gerald L. Andriole(Institut thématique Génétique, génomique et bioinformatique), Robert L. Grubb
Cited by 60
Related Papers
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2019|1.6k
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
|Nature Genetics|2007|1.1k
Prostate Cancer Screening in the Randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: Mortality Results after 13 Years of Follow-up
|JNCI Journal of the National Cancer Institute|2012|1.1k
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
|Controlled Clinical Trials|2000|1k